News About: Pharm. Industry
Aronamin and Nitracare wins first brand awards
Ildong Pharm’s Aronamin (multivitamin) and Natracare (sanitary napkin) were selected as 2009 premium brands, in this year’s best brand ceremony hosted by Korea Consumers' Forum and Korea Economy Daily.
The First Br...
Export drive to sweep pharmaceutical industry
Fierce competition in the domestic medicine market is making it harder for companies to do business.
Analysts expect a large number of mergers and acquisitions (M&A) to take place among companies, and restructuring...
Park Sun-dong named vice chairman of KRPIA
The Korean-based Pharmaceutical Industry Association said on February that it appointed Park Sun-dong, president of BMS Korea, as its new vice chairman.
Park will replace Kim Chin-ho to serve as the KRPIA's ninth v...
Foreigner buying Keunwha stocks
Foreign investors are resuming buying stocks in Keunwha Pharm, mainly due to higher ownership of major shareholders, stock analysts said.
Foreign investors increased their holding in Keunwha by 3.46 percent between...
Drug ads for alopecia and pain killer to grow sharply
Amid the rapid population aging and falling birthrates, the number of drug advisements for alopecia and analgesics is expected to increase, according to the Drug Ads Deliberation Committee under the Korea Pharmaceutic...
Choong-wae joins 100-10 club
Backed by the popularity of 10 medicines achieving more than 10 billion won in sales last year, Choong-wae Pharm has joined the 100-10 club.
The 10 items include three amino acid infusions, itopride, pitavastatin, ...
Moon named head of Bayer Schering Korea over specialty medicine business unit
Moon Hee-suk, former head of BMS Korea, was named general manager of special therapeutics unit for Bayer Schering Korea.
Moon will be responsible for taking charge of marketing Bayer Schering’s new medicines, such ...
Korea to work with Canada on biotechnology projects
Kyunggi Province said that it has agreed with the Canada LifeSciences British Columbia (LSBC) to work together in wide-ranging areas of biotechnology.
The province officials said that that it will sign a memorandum...
Dong-A breaks W700 billion barrier in sales
Dong-A Pharm reported on February 5 that it earned 43.2 billion won on sales of 702.3 billion won last year, up 10.4 percent in 2007.
Dong-A’s operating profit increased 12.8 percent from a year ago to 81.7 billion...
Wholesalers all-out to maintain proper margin policy
Domestic pharmaceutical wholesalers are finding it increasingly difficult to boost their bottom line amid drugmakers’ intention to slash wholesalers’ margin and stiffer competition.
GlaxoSmithKline has recently not...
